ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[FASLG, PRL, HHEX, CCR2, HGS, CX3CR1, PLK2, TIE1, CXCL10, TEK, PF4]
GO:0036499;PERK-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.292166977892469;0.0026782155121157316;0.6960420709600095;[CCL2, ATF3]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[HAVCR2, ACTN4, CHI3L1, TLR7, TLR4, TLR2, CCL19, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[PLXND1, CXCL13, CDH5, C3AR1, PROK2, GHSR, HGS, ADAM12, AGTR1, C5AR1, JUP, PLK2, TNFSF12, CXCL10, NRP1, FASLG, PRL, HHEX, CCR2, ANXA1, ANXA3, GAB1, CEACAM1, CHI3L1, ENG, CX3CR1, PTGS2, DLL1, GPNMB, CXCR2, TIE1, LRG1, TEK, PF4]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, PKN1]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[ABHD12, CHL1, SLITRK6, DRD4, SCN1A, NR4A2, CXCL12]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[LYN, PRL, GHR, GH1, CCL2, CCR2]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, GHSR, IFNG, BLK, CNR1, CCL5]
GO:0048247;lymphocyte chemotaxis;7.0;0.7671156992804218;0.7344772148974115;9.303101852057495;94.37808318069546;5.926926025970411;0.003158749509297446;0.6540226378555745;[CCL13, CXCL9, CCL23, CCL20, DEFA1, CXCL13, CXCL16, CXCL10, CXCL11, CCL8, CCL7, CCL5, CCL4, CCL2, XCL1, CCL1, CCL19, CCL18, CCR2]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, SLA2, MYB, MEF2C, ATF3, ELANE, PKIG, EZH2, PAWR, PAX5, AES, MMP12, FLNA, NR1H2, LGR4, GMNN, DACH1, TLE4, FOXO1, NACC2, WFS1, BCL6, CIITA, FASLG, HHEX, RFC1, XCL1, RBBP8, E2F7, KLF8, KLF5, ZNF608, EDNRB, RUNX2, PCBP3, EGR1, BCL11A, IFNA2, PTPRK, XPO1, CD36, ARID4A, BASP1, CCNE1, TGFB1, CBX4, CAV1, HMGA1, NR4A2, MXD1, HMGB2, IFNG, FBP1, MEIS2]
GO:0048246;macrophage chemotaxis;8.0;1.0;0.875;9.628524252492122;95.91852822164125;7.212124270218933;0.0032103068185073717;0.7438283705770736;[CX3CR1, LGALS3, EDNRB, NUP85, CCL5, CCL2, AZU1]
GO:0045651;positive regulation of macrophage differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;7.212124270218933;0.0281402778535103;0.7650689957573628;[PF4]
GO:0048245;eosinophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;6.7325511899570465;0.004360933283440787;0.740543606130341;[LGALS3, CCL13, CCL23, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, POLA2, BCL6, IFNG, AKT1, RAN]
GO:0010536;positive regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;2488.7782735422925;7.8311634786251565;0.08329716906043155;0.8329150168128974;[GH1, CCL5, IL6R]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[FASLG, CCL2]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR, CCL5, CCR5]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, LILRB1, INHBA, PDCD1LG2, XCL1, TLR4, HAVCR2]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, HMGB2, CDH3, AKT1, GHSR, ARG1, MMP12, AGTR1, C5AR1, TGFA, IQGAP3, CCL5, TGFB1, EGR3, TNFSF12, NR4A1, LRG1, CXCL12, TEK]
GO:0045653;negative regulation of megakaryocyte differentiation;8.0;1.0;0.875;9.628524252492122;350.11976986482637;8.16763571524637;0.011718193610040062;0.7926932703116032;[PF4]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[CCL7]
GO:0002920;regulation of humoral immune response;5.0;0.5916390046238794;0.58606051417286;8.201407896851975;25.624977988756285;4.925043363760852;8.576449523007288E-4;0.5421079585215889;[C5AR1, CXCL13, IGHG1, IGKC, CD19, IGLV1-44, C3AR1, CR2, CR1, FCER2, FCGR2B, IGKV3-20]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, FCER2, CCL2, TLR4, TLR2]
GO:0045662;negative regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;6.518977089658987;0.0038363580074348307;0.6565011041187423;[TGFB1, DLL1, CXCL10]
GO:0030816;positive regulation of cAMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.526741558182179;1396.5025295312637;6.139487467954083;0.04673968289273128;0.7292146864874571;[CXCL10, LHCGR, CXCL9, CXCL11, RAMP1, TSHR, PF4]
GO:0031584;activation of phospholipase D activity;8.0;1.0;0.875;9.628524252492122;67.57805180902054;7.9853141584524145;0.0022617765777498177;0.7833693374183408;[CCL5]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, PCNA, C5AR1, TGFB1, ANXA3, SULF2, TGFBR3, CXCL12, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[FGF5, TNFSF11, PDGFRB, GAB1, BTC, KIT, CHI3L1, HBEGF, ENG, CD19, CCL19, ICOS, TGFB1, TRAT1, EGF, PTK2, CD28, NOX4, TEK]
GO:0043922;negative regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.3838172918008;7.292166977892469;0.009116441235236167;0.8053507106995271;[CCL5, CCL4]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[PTGS2, KLRK1, AKT1, CD36, DNM2, IFNG, PTX3, TLR4]
GO:0090312;positive regulation of protein deacetylation;9.0;0.8436909121759173;0.8180860812682478;9.500690880982237;445.87784815594415;6.686031174322154;0.014923130313768376;0.7381645703673706;[TGFB1, LRRK2, BCL6, IFNG]
GO:1903543;positive regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;273.97956964224545;7.069023426578259;0.009169849630321672;0.757750811958709;[IFNG, HGS, SDC1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[AKT1, TNFSF11, F2R, NDFIP2, PLK2, TNFRSF10B, CCDC22, FASLG, NUP62, CD36, LTF, FLNA, CCL19, CD4, LTBR]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[FASLG, IL6R, DCC, TNFRSF1B, IFNG, TGFB1, SORT1, TNFSF12, G0S2, TNFRSF10B, INHBA]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[MEF2C, CXCL9, TNFSF14, FLT3LG]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, MYB, AKT1, TNFSF11, ICOSLG, COL8A1, HHLA2, KLRK1, ICOS, ELANE, LYN, EGR3, JUP, TNFSF14, AZU1, VNN1, CD28, CD24, NRP1, CD3E, CD36, CCR2, HLA-DPA1, HAVCR2, ANXA1, PDCD1LG2, CEACAM6, PTAFR, PDPN, FLNA, CCL19, LILRB1, LILRB2, HLA-DPB1, CD83, SIRPG, CXCL13, PYCARD, GRAP2, IL6R, OLFM4, ADAM9, CD274, BLM, CORO1A, BTLA, NLRP3, TGFB1, CAV1, CXCL12, BCL6, DOCK5, SIRPB1, EMILIN2, DNM2, IFNG, XCL1, CCL5, CCL2, CD4, CD6, TEK]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[ARG1, SLC11A1, DEFA1, PF4]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, F13A1, LAMP2, CD36, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, STXBP2, FLNA, LYN, TGFB1, EGF, LHFPL2, PPBP, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, FGF5, TNFSF11, PDGFRB, MEF2C, MAP2K2, BTC, CSF2RB, IQGAP3, RASGRP4, TGFB1, PTK2, LAT, LRRK2, CCR5, SPTAN1, MAP4K1, DUSP6, KIT, HBEGF, CCL5, CCL2, NCAM1, EGF, IL2RB, TEK]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[TGFB1, TSC2, TMEM100, CCL5, AKT1, CCL2]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, LYN, CXCL10]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, TGFA, FGF5, RACGAP1, NUP62, PDGFC, SVIL, TGFB1, TAS2R13, CDC6, PPBP, CIT, BTC]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, IFNG, TNFSF11]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, SLC8A1, CTGF, F2R, CACNA2D3, CALCRL, PSEN2, CORO1A, CCR1, CAV1, ATP2A3, FASLG, CCR5, TRPC7, TRPC1, TMEM37, XCL1, SLC24A1, SLC24A4, CCL8, CCL5, CCL19, RAMP1]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, PCNA, GPNMB, NACC2, CCL2, SFN, E2F7, PLK2, CNOT3, EZH2]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, AKT1, CCR6, ANXA1, ANXA3, MMP9, IFNG, ADAM9, PFN1, HBEGF, PTGS2, TGFB1, PLK2, TEK]
GO:0048260;positive regulation of receptor-mediated endocytosis;8.0;0.811012628672052;0.780506314336026;9.34084218004034;175.1727623766804;5.8650506222523235;0.005862874711496551;0.6749389615747303;[CCL19, EGF, SELE, DNM2]
GO:0033634;positive regulation of cell-cell adhesion mediated by integrin;6.0;1.0;0.8231203125901445;9.628524252492122;97.9646140837123;8.390779266560578;0.003278787470953165;0.7522251544931926;[CCL5, CXCL13]
GO:0031334;positive regulation of protein complex assembly;6.0;0.612588685250814;0.6294146552155515;8.094593892566166;105.21570715161425;4.251620688548686;0.0035214750303757575;0.5405483923231058;[CYFIP1, CXCL13, PYCARD, TCL1A, PFN1, TGFB1, CD36, PSRC1, IFNG, TLR4, GSN, BIK, NR1H2, RPA1, GTF2H1, RPA3]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, AKT1, PF4]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[EGR3, NR4A1, CCL5, CCL2]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, CSF3R, C5AR1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CXADR, CCL20, PPBP, CXCL10, CXCL11, XCL1, S100A8, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, HMGB2, AKT1, GHSR, EGR3, ARG1, TNFSF12, NR4A1, LRG1, CXCL12, AGTR1, TEK]
GO:0033625;positive regulation of integrin activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;140.3817219977405;8.16763571524637;0.004698449899916962;0.7686126355688037;[CXCL13]
GO:0033622;integrin activation;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;7.57984905034425;0.0013529121422039536;0.6778748447945537;[CXCL12, TLN1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, GAS2L1, BARD1, TGFB1, CDKN2C, DHCR24, INHBA]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[TGFA, GRM5, CCL5, STAP1, ACE, EGF, CD24]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, PADI2, FPR1, FPR2, ELANE, LYN, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, ANXA5, F5, SERPINB10, PTAFR, ALOX5, FLNA, GSN, LRG1, SLCO4C1, SIGLEC5, PF4, HP, F13A1, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, ATP8B4, DEFA4, DEFA1, LCN2, LAT, ITGAM, FCAR, FCGR3B, CR1, TNFRSF1B, PECAM1, BPI, ACPP, CCL8, CCL5, FCGR2A, P2RX1, FOLR3, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, CHIT1, SLPI, CRISPLD2, TLN1, STXBP2, MGST1, CCR1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSG, CD36, SPTAN1, CAMP, CD33, MME, RHOG, LAT2, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, STX11, CXCR1, CXCR2, CD58, LHFPL2, LILRB2, LILRB3, QPCT, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, C5AR1, MGAM, TGFB1, SYT2, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, SYNGR3, MMP9, CHI3L1, LTF, CLEC12A, RETN, EGF, CD9, S100P, PTX3]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[RACGAP1, EZH2, DENND1B, NRP1, ARHGAP6, RHOG, CCL13, CCL19, CCL18, RANBP1, CCL23, CCL20, SIPA1, CXCL13, RGS1, F2R, TSC2, ACAP1, PRTN3, ADAP2, LRRK2, TBC1D9, ARAP3, ALDH1A1, XCL1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, PDGFRB, CXADR, AGTR1, S100A8, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, CCR10, CCR1, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, FFAR2, CCR6, CCR5, CCR2, ANXA1, RHOG, GAB1, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, PF4]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD83, TFRC, SIRPG, PYCARD, GRAP2, MYB, AKT1, TNFSF11, IL6R, ICOSLG, CD274, BLM, HHLA2, CORO1A, KLRK1, BTLA, NLRP3, ICOS, LYN, TGFB1, EGR3, TNFSF14, CAV1, VNN1, BCL6, CD28, CD24, CD3E, SIRPB1, CCR2, HLA-DPA1, HAVCR2, ANXA1, PDCD1LG2, IFNG, XCL1, CCL5, CCL2, CCL19, LILRB1, LILRB2, CD4, CD6, HLA-DPB1]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, ADAM9, TNFRSF1B]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PYCARD, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, AZU1, DEFA1, CXCL10, IFNA5, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, IFNG, TLR8, TLR7, UNC93B1, SAMHD1, LILRB1]
GO:0035754;B cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;7.9853141584524145;0.003205147533980157;0.7833693374183408;[CXCL13]
GO:0060550;positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;315.71736046966464;9.777073627680469;0.01056677592774235;0.9324289523296623;[IFNG]
GO:0060552;positive regulation of fructose 1,6-bisphosphate metabolic process;8.0;1.0;0.875;9.628524252492122;179.13735624701934;9.777073627680469;0.005995566100433959;0.875;[IFNG]
GO:2001264;negative regulation of C-C chemokine binding;6.0;1.0;0.8231203125901445;9.628524252492122;47.53015703769362;9.777073627680469;0.0015907915816874183;0.8231203125901445;[CCL23]
GO:0045859;regulation of protein kinase activity;9.0;0.5608425510848448;0.6766619007227115;8.333797084897721;159.5555227474585;3.0974744418360864;0.005340179755709658;0.5546456121830788;[, AKT1, PROK2, FPR1, IQGAP3, FLRT2, PRKAR2B, PDGFC, SFN, ELANE, LYN, ACE, FZD5, CDC6, AZU1, NOX4, PKIG, EZH2, CDKN1A, LRRC4, DUSP2, DUSP1, DUSP6, LRRC19, CCL19, CDKN2C, GTF2H1, PKN1, PYCARD, MAP2K2, F2R, ADAM9, BLM, TNFRSF11A, PKMYT1, DRD4, TNFRSF10B, CXCL10, CSPG4, LAT, LRRK2, HHEX, CCL5, CCNH, TCL1A, PPP2R1A, TNFSF11, ACSL1, SLC11A1, TGFA, EGR1, PTK2, CD24, MAP4K1, CEACAM1, KIT, TLR4, CXCR4, IL6R, PDGFRB, TSC2, HGS, CCNE1, C5AR1, ADRB2, STAP1, TGFB1, CAV1, GH1, GHR, GRM5, LRRTM4, NUP62, PSRC1, IFNG, CHI3L1, LTF, EGF, CD4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[EDNRB, GPR171, C3AR1, AKT1, PROK2, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, ADCY9, AGTR1, FPR1, FPR3, FPR2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, GPR18, GPR19, GPR25, GABRB1, CD3E, CCR9, FFAR2, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, AVPR1A, SORCS3, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD4, CXCR1, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, F2R, NPY1R, DGKZ, SPNS1, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PTGIR, GLP2R, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, TSHR, OR11A1]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[CHRM2, CHRM1, GRM5, RGS1, PTGDR, LHCGR, PTGIR, GPR37, ANXA1, GLP2R, NPY1R, MC3R, ADCY9, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, CNR1, HRH4, FLNA, CCL2, S1PR3, DRD4, CCR1, ABCA1, GABBR1, HTR1E, TSHR, MARCO, RAMP1, LGR4]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, TGFB1, FPR2, PTK2, KIT, TEK, CCL19]
GO:0060559;positive regulation of calcidiol 1-monooxygenase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1344.9571378328073;8.67846133901236;0.04501450502042472;0.8590579283277371;[IFNG]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, PADI2, FPR1, FPR2, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, SIGLEC5, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, LCN2, ITGAM, FCAR, FCGR3B, CR1, TNFRSF1B, PECAM1, BPI, ACPP, FCGR2A, P2RX1, FOLR3, LGALS3, ANPEP, SLC11A1, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSG, CD36, SPTAN1, CAMP, CD33, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, LILRB2, LILRB3, QPCT, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, CHI3L1, LTF, CLEC12A, RETN, S100P, PTX3]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[PYCARD, HAVCR2, XCL1, SIK1, FLNA, NLRP3, WFS1, NLRP12, CCDC22, EZH2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD3E, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, PDCD1LG2, XCL1, CD274, BLM, HHLA2, CORO1A, CCL5, CCL19, LILRB2, CD4, CD6, CD28, HLA-DPB1, CD24]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, CTGF, EDNRB, AKT1, GHSR, LHCGR, POR, ADCY9, ABCB4, SLC30A10, FOXO1, PRKAR2B, LYN, EGR1, EGR2, TGFB1, CAV1, CDC6, NR4A2, NR4A1, CXCL12, HHEX, ANXA1, ARG1, GLP2R, TGFBR3, CEACAM1, TLR2, RETN, PTGS2, GNAI1, SORT1, TSHR, TEK]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, MEF2C, TGFB1, ARG1, CAV1, NOX4, XCL1]
GO:0030857;negative regulation of epithelial cell differentiation;6.0;0.6634067003016617;0.6548236627409754;8.638125548464245;143.89713366415532;6.139487467954083;0.004816107564726769;0.6370939872166814;[JAG1, CAV1, DLL1, IFNG, S1PR3, EZH2]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5]
GO:0002725;negative regulation of T cell cytokine production;9.0;0.8933024483968273;0.8428918493787028;9.566003895510788;628.7135452718476;7.697632086000634;0.021042476554793195;0.7898978880348613;[ARG1, IFNA2, XCL1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[SLC11A1, CCL19]
GO:0070234;positive regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.47524002355703;7.138016298065211;0.00520361636495672;0.7802794972956796;[CD274, CCL5]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, CTGF, CXCL16, FGF5, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, BTC, IFNA10, TGFA, ADRB2, PDGFC, IFNA21, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, IFNG, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, EGF, CCL20, CMTM2, FCGR2B, PF4]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, VRK1, CORO1A, PTK2, ANXA1, RHOG, ARAP3, KIT, RHOU, CCL13, FGD4, CCL7, PDPN, CCL2]
GO:0042119;neutrophil activation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;20.951462914457938;3.578594911188161;7.012266086544604E-4;0.5061298227699893;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, PADI2, FPR1, FPR2, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, SIGLEC5, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, LCN2, ITGAM, FCAR, FCGR3B, CR1, TNFRSF1B, PECAM1, BPI, ACPP, CCL5, FCGR2A, P2RX1, FOLR3, LGALS3, ANPEP, SLC11A1, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSG, CD36, SPTAN1, CAMP, CD33, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, LILRB2, LILRB3, QPCT, IL18RAP, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, C5AR1, MGAM, CXCL6, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, CHI3L1, LTF, CLEC12A, RETN, S100P, PTX3]
GO:0045627;positive regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2605.164725512912;7.9853141584524145;0.08719251886688177;0.8709243021859774;[ANXA1, CCL19]
GO:0010560;positive regulation of glycoprotein biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.34084218004034;731.8700557117284;6.832634648514029;0.024495032124383954;0.7244212536750128;[PAWR, CCL19, RAMP1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, RHOG, TBC1D9]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[, ADRB2, GNAI2, CCL5, STMN1]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[PRTN3, CCL19]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, CORO1A, XCL1, MCM2]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHI3L1, XCL1, CCL13, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL20]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, P2RY6, CCL5, NOX4]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[CCL5, CD28]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[CCL5, SLPI, LTF]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, HLA-DPA1, IFNG, HLA-DQB1, PTAFR, NCAM1, FCGR1B, HLA-DQA1, HLA-DRB4, HLA-DPB1, HLA-DRA]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, RHOG, IFNG, EPHA3]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, BRCA2, ROPN1L, FBXO5, RUNX2, BTK, CCL19, FZD5, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.87544056254812;6.558197802812269;0.003945184914619341;0.7103865406232063;[ARG1, NR1H2, IFNG]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, ATP1B1, AGTR1, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, CCR9, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC1, AVPR1A, XCL1, CX3CR1, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0051873;killing by host of symbiont cells;7.0;0.811012628672052;0.7564256795932265;9.454170865347344;141.48138775290343;7.57984905034425;0.004735254723107338;0.738553198190834;[CTSG, AZU1, ELANE, CAMP, PF4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CXCL6, CXCL9, HMGB2, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, CXCL10, CXCL11, PF4]
GO:2000503;positive regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;7.9853141584524145;0.03348691152528284;0.8407982897480031;[CCL7, CCL5, CCL4, XCL1]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[ICAM2, PYCARD, IL18RAP, LAG3, CD180, CLEC4D, BTK, S100A8, LY96, KLRK1, LYN, CAV1, SH2D1A, MARCO, ITGAM, HMGB2, CTSS, FFAR2, MUC15, CD36, HAVCR2, MMP12, TLR1, TLR8, TLR10, TLR7, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, CCL5]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, TLR2]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[CTGF, PYCARD, TNFSF11, PDGFRB, F2R, EPHA3, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFC, CCR1, TGFB1, MARCO, NOX4, NRP1, TREM2, CD36, HAVCR2, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, TIE1, CD4, TEK]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, KMO, CHI3L1, XCL1, RBMX]
GO:0072679;thymocyte migration;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;31.84507234699532;9.083926447120524;0.0010658259127495017;0.839552420951524;[CCL20, CCR6]
GO:0002826;negative regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;172.20109340032639;7.8311634786251565;0.005763415625186428;0.7754860644832351;[XCL1, HAVCR2]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, GSN, CCL20, ZYX]
GO:2000502;negative regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1002.759017369874;9.083926447120524;0.03356144188684441;0.8969813732811862;[KLRK1, CCL2]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[PDGFRB, GAS2L3, CXADR, TLN1, PFN1, CORO1A, RACGAP1, CORO2A, BCL6, NRP1, ARHGEF10L, CXCL1, ANXA1, RHOG, GAB1, KIT, RHOU, FGD4, FLNA, KRT19, ZYX]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, FPR1, TGFA, IQGAP3, PDGFC, ELANE, FZD5, CDC6, NOX4, CD24, EZH2, MAP4K1, DUSP6, KIT, TLR4, CXCR4, CCL19, PKN1, PDGFRB, MAP2K2, F2R, ADAM9, C5AR1, TNFRSF11A, ADRB2, DRD4, TGFB1, GH1, CSPG4, LRRK2, GHR, PSRC1, IFNG, LTF, EGF]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[IL12RB2, IFNG]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CCL5, PDGFC, PDGFRB, F2R, PTK2, GH1, KIT, CD28, TEK]
GO:0035684;helper T cell extravasation;9.0;0.8933024483968273;0.8428918493787028;9.474373572664863;63.467001142674015;9.777073627680469;0.002124183411652594;0.896240625180289;[CCL2]
GO:0034112;positive regulation of homotypic cell-cell adhesion;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;52.782758271627834;7.9853141584524145;0.001766591417952991;0.7314896500084853;[CCL5, PDPN, TNFSF11]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, LGALS3, PDGFRB, TRPC1, F2R, ATP1B1, XCL1, KCNE3, CD19, CCL5, CCL4, CCL2, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, CXCL12, F2RL3]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[CCL2, DLL1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0008064;regulation of actin polymerization or depolymerization;9.0;0.6729672293956388;0.7327242398781084;9.05316010758856;119.88573797499163;4.556717802602145;0.004012467759863614;0.6292713855144111;[CYFIP1, PYCARD, PFN1, CORO1A, CXCL12, SPTAN1, CIT, EPS8L1, GSN]
GO:0033141;positive regulation of peptidyl-serine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;940.2079225453168;6.781341354126479;0.03146791303539702;0.7792270645443136;[IFNA5, IFNA4, IFNA7, IFNA14, IFNG, IFNA16, IFNA2, IFNA8, IFNA21, IFNA10]
GO:1901741;positive regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.2013099653272;6.8867018697843045;0.011821329983997786;0.7484268790654467;[CXCL9, TNFSF14, FLT3LG]
GO:1901740;negative regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.26084893783826;8.67846133901236;0.011823322699826135;0.8400575416471059;[CXCL10]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IFNA2, GHR, CCL5, IL6R, LYN, GH1, IFNG, KIT]
GO:2000518;negative regulation of T-helper 1 cell activation;11.0;1.0;0.9324289523296623;9.628524252492122;343.04631122454646;9.777073627680469;0.011481451315049374;0.9324289523296623;[XCL1]
GO:0010819;regulation of T cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;194.94068539511468;7.292166977892469;0.006524489304947852;0.7881627702307852;[CXCL10, TNFSF14, CCL5, XCL1, CXCL13, CCR2]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL10, CXCL9, CXCL11, DEFA1, CXCL16, CCR2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[SLC8A1, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, EGR1, TGFB1, CAV1, NR4A2, CXCL12, NOX4, CD24, KCND2, AGTRAP, TGFBR3, TLR2, CXCR4, PTGS2, TEK]
GO:0002518;lymphocyte chemotaxis across high endothelial venule;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;95.76437754181396;9.777073627680469;0.003205147533980157;0.875;[CXCL13]
GO:2000513;positive regulation of granzyme A production;7.0;1.0;0.8509193652572005;9.628524252492122;76.06278562175245;9.777073627680469;0.002545752982697279;0.8509193652572005;[XCL1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2C, AGTR1, FPR1, FPR2, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, AZU1, ARHGAP6, DUSP1, DUSP6, PTAFR, PKN1, LGR4, CTGF, KCNH1, MSH6, MSH2, BLK, LY96, TNFRSF10B, BMX, CORO2A, LRRK2, TNFRSF1B, CCL5, CCL2, E2F7, SH2B1, IL2RB, TNFSF11, BTC, BTK, RACGAP1, CCR1, PTK2, RGL4, CD24, RGL1, BRCA2, CCR9, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, KIT, PCNA, GNAI2, RAMP1, CELSR1, CCRL2, PDGFRB, DOK3, PSEN2, RASGRP4, GH1, GHR, GRM5, EPS8L1, EGF, TEK, CYFIP1, STMN1, ADCY9, LGALS12, PLK2, CDKN1A, NFAM1, CIT, HBEGF, GSN, CCL20, IL5RA, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, LHCGR, MAP2K2, DGKZ, NRBP1, RAB32, MELK, CALCRL, DHCR24, BCL6, CNOT3, CSPG4, LAT, TREM1, CX3CR1, EDNRB, PPP2R1A, CHEK1, PTGDR, SIK1, CCR10, PRL, RALGPS2, MAP4K1, RHOG, AVPR1A, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, SIPA1, SIRPG, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, DOCK5, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, NCAM1, TSHR]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[TNFSF11, FFAR2, CCR2, IL17RB, BTK, AGTR1, TLR10, TLR7, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, PTGS2, PLA2G7, CNR1, CCL4, CCL18, CCL23, NLRP12, CD6, CD28]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, LTF, PF4]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[MMP12, CCL19]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR2]
GO:1901509;regulation of endothelial tube morphogenesis;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;45.7200117395938;8.390779266560578;0.0015302076475850206;0.7522251544931926;[CXCL10]
GO:0032834;positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;13.0;1.0;0.9625549647676366;9.628524252492122;3627.31071452397;9.083926447120524;0.1214028252474149;0.9271073857191605;[IFNG]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCR1, CXCR1, CCL5, CXCR2, CXCR4, CCR6, CCL19, CCR5, CCR2]
GO:0010820;positive regulation of T cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1408.745447987039;7.379178354882098;0.04714944235553481;0.8098004765652196;[TNFSF14, CCL5, XCL1, CXCL13, CCR2]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCL19]
GO:0050726;positive regulation of interleukin-1 alpha biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;1101.0209221136138;9.777073627680469;0.03685017940864447;0.896240625180289;[CCL20]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, BTK, AGTR1, PLA2G7, CD19, ELANE, LYN, BST1, CD28, FFAR2, CCR2, ANXA1, IL17RB, TLR10, TLR7, TLR4, TLR2, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, CDH5, IGHG1, GHSR, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, BCL6, IGKV3-20, TNFAIP6, CR2, CR1, TNFRSF1B, XCL1, CNR1, CCL5, CCL4, CD6, TEK, FCGR2B]
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;71.50580126066325;7.379178354882098;0.0023932348171512878;0.7004918368257019;[CXCL12, SCN1A]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCL19]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, MEF2C, KCNQ1, ABCB4, ABCA1, EGR1, JUP, NOX4, EZH2, GABRB1, ANXA1, ARG1, PTAFR, PTGS2, GNAI1, P2RY13, SLC8A1, CDH1, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, ALPL, SLC26A3, LRRK2, DNM2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CXCL12]
GO:0045948;positive regulation of translational initiation;9.0;0.7586651285174919;0.775573189439035;9.39368466141472;1253.3709905068713;6.409777797693995;0.04194919909160693;0.7240369598395108;[CCL5]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0035782;mature natural killer cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;95.76437754181396;9.777073627680469;0.003205147533980157;0.896240625180289;[XCL1]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[PTGER2, TGFBR3, P2RY6, AKT1, CCL19, PTGDR]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, MEF2C, SPINT1, BTK, SFN, LYN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, PRL, PTPRK, BRCA2, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, TLR2, PTGS2, GPNMB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PKN1, SIRPG, CDH5, DACH1, F2R, TSC2, HGS, CD274, NACC2, IGFBP7, TGFB1, RARRES3, CAV1, HMGA1, DHCR24, INHBA, BCL6, OGN, CXCL1, NUP62, PTGIR, TGFBR3, IFNG, XCL1, DLL1, CCL8, CCL2, E2F7, CD9, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, AKT1, PROK2, MEF2C, CLDN7, AGTR1, ATF3, HHLA2, IQGAP3, PDGFC, ELANE, LYN, CDC6, CDKN1A, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, MMP12, HBEGF, PTAFR, PTGS2, EPCAM, FLNA, CCL19, IL12RB2, LRG1, HLA-DPB1, CHRM1, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, BCL6, FASLG, XCL1, CX3CR1, CCL5, KLF5, TCL1A, EDNRB, SKP2, ICOSLG, FLT3LG, RUNX2, BTC, TGFA, EGR1, EGR3, TNFSF12, PTK2, BST1, CD28, CD24, CD320, NRP1, NRP2, PRL, CD3E, CCR2, RHOG, PDCD1LG2, AVPR1A, CEACAM6, KIT, GNAI2, CXCR2, LILRB2, SIRPG, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, C5AR1, LTBP3, TGFB1, NR4A1, HMGB2, LAMC2, CXCL5, GLP2R, MMP9, TGFBR3, IFNG, LTF, DLL1, S1PR3, EGF, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, AKT1, MEF2C, ATF3, JAG1, JUP, FZD5, PAX5, MMP12, ENG, EPCAM, NR1H2, ATAD2, GTF2H1, PF4, PLXND1, FOXO1, CXCL10, MAFF, CIITA, HHEX, CEBPE, E2F5, E2F7, KLF5, POU2AF1, CCNH, TNFSF11, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, TLR4, TLR2, LILRB1, ARID4A, ADRB2, NLRP3, TGFB1, HMGA1, INHBA, NR4A2, NR4A1, TCF4, HMGB2, SLC40A1, ARHGEF10L, CKAP2, DLL1, MEIS2, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, LRP1, C5AR1, SLC30A10, CORO1A, CCL2, WFS1, GABRA5, NR4A2]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[MYB, AKT1, SKP2, IL6R, PDGFRB, MMP9, HBEGF, CALCRL, PTAFR, PTGS2, GNAI2, CCL5, ELANE]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, CCL4, TRAT1, P2RX5, CD4]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, XCL1, HAVCR2]
GO:0070100;negative regulation of chemokine-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;306.6761070193533;8.16763571524637;0.010264173311360264;0.7926932703116032;[CCL5, PADI2]
GO:0051262;protein tetramerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.917261223318797;0.00140677858073304;0.5745892802266999;[CDA, NUP54, ACPP, FBP1, NLGN1, HM13, SAMHD1, CD79A, CCL5]
GO:2000538;positive regulation of B cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1000.5321764499969;9.083926447120524;0.03348691152528284;0.8969813732811862;[XCL1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, MEF2C, PTGIR, IFNG, OGN]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, TLR4]
GO:2000412;positive regulation of thymocyte migration;11.0;0.9326813400603323;0.8987696223598284;9.587702257971866;410.00503100626815;9.083926447120524;0.013722499407208136;0.8969813732811862;[XCL1]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD274, HHLA2, CD3E, KLRK1, GRAP2, BTLA, AKT1, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CAV1, PDCD1LG2, CD28, CD24]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, TRPC1, F2R, CXCL10, CXCL11, CD19, XCL1, F2RL3]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, LGALS3, CXCL12, CCL2]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[SGCE, BASP1, MEF2C, EGR3, CXCL10, HBEGF]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[CCL2]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, LILRB1, CCL19]
GO:0071663;positive regulation of granzyme B production;7.0;1.0;0.8509193652572005;9.628524252492122;91.76586570378727;9.083926447120524;0.0030713209411884286;0.8154717862087246;[XCL1]
GO:2000549;positive regulation of dendritic cell dendrite assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.777073627680469;0.006704083591926775;0.896240625180289;[CCL19]
GO:2000309;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;7.0;1.0;0.8509193652572005;9.628524252492122;85.21640127316344;9.083926447120524;0.0028521162608307568;0.8154717862087246;[IFNG]
GO:0035768;endothelial cell chemotaxis to fibroblast growth factor;9.0;1.0;0.896240625180289;9.628524252492122;91.92245058705075;9.777073627680469;0.003076561696314011;0.896240625180289;[CXCL13]
GO:2000545;negative regulation of endothelial cell chemotaxis to fibroblast growth factor;11.0;1.0;0.9324289523296623;9.628524252492122;1104.3280194323595;9.777073627680469;0.03696086497970853;0.9324289523296623;[CXCL13]
GO:0051712;positive regulation of killing of cells of other organism;5.0;0.7192862368539868;0.6498841302879137;9.05316010758856;72.11799800547139;7.292166977892469;0.0024137244912587163;0.6631627702307852;[FCER2, IFNG, ARG1]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[CXCL12]
GO:0034393;positive regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.00837127343294;7.212124270218933;0.004250855886408647;0.7650689957573628;[IFNG]
GO:1904659;glucose transmembrane transport;9.0;0.8436909121759173;0.8180860812682478;9.36615998802463;37.512677707980714;6.343086423195323;0.0012555155636680114;0.7206263598461826;[SORT1, PPBP, SLC5A4]
GO:0002676;regulation of chronic inflammatory response;7.0;0.7586651285174919;0.7302519295159464;9.0689084645567;34.07149622250282;7.57984905034425;0.0011403423162113378;0.738553198190834;[CCL5]
GO:2000558;positive regulation of immunoglobulin production in mucosal tissue;10.0;1.0;0.9152410118609203;9.628524252492122;466.5056489120817;9.083926447120524;0.015613524241260885;0.8797934328124444;[XCL1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, PYCARD, CD36, CCR2, HAVCR2, TLR1, TLR4, TLR2, PTAFR, LY96, CCL19, FZD5, AZU1, CD2, PF4]
GO:2000556;positive regulation of T-helper 1 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;941.8516928651488;9.083926447120524;0.03152292854870455;0.8797934328124444;[XCL1]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[F2R, FASLG, XCL1, CCL19, CCR5]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[FOXO1, DNM2, CCL19]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[NLRP3, XCL1]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, CCL1, FPR2, PLA2G7, CCR2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, CXCR2, C3AR1, XCL1, CCL19, PF4]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CXCL6, CXCL9, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, C3AR1, CCR6, IL6R, CCR2, XCL1, C5AR1, FPR2, PLA2G7, CCL7, CCL5, CXCR2, CCL4, CCL1, CCL19, CCR1, TNFSF14, PPBP, CXCL10, CXCL11, CXCL12, PF4]
GO:0043950;positive regulation of cAMP-mediated signaling;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;239.5163045814748;6.686031174322154;0.008016395163662574;0.7169239451870815;[CXCL10, CXCL9, CXCL11, PF4]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[NRP1, CXCL12]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, HP, CXCL13, PYCARD, IGHG1, IL6R, SLC11A1, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, IGKV3-20, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, ANXA3, TLR1, IGHD, BPI, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, IGKC, CCL20, CD4]
GO:0002687;positive regulation of leukocyte migration;8.0;0.6634067003016617;0.7067033501508309;8.963547948898873;238.70113796770806;4.956792062075433;0.007989112270702124;0.6284905765689417;[CXCL6, CXCL9, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, LGALS3, C3AR1, CCR6, IL6R, CCR2, IL1R1, XCL1, C5AR1, PTAFR, FPR2, PLA2G7, CCL8, CCL7, CCL5, CXCR2, CCL4, CCL1, CCL19, ELANE, CCR1, TGFB1, TNFSF14, CCL20, PPBP, CXCL10, CXCL11, CXCL12, PF4]
GO:0010508;positive regulation of autophagy;7.0;0.7192862368539868;0.710562483684194;9.040737587590003;216.89043707272492;5.132682728539097;0.007259127740103463;0.6134049986888465;[LRRK2, TSC2, IFNG, ADRB2, FOXO1, PLK2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPIB, AKT1, MEF2C, PADI2, ATF3, IQGAP3, JAG1, JUP, AZU1, MMP12, PTAFR, ATAD2, LGR4, CTGF, BLM, FOXO1, CXCL10, CIITA, HHEX, CCL5, E2F5, E2F7, POU2AF1, CCNH, TNFSF11, EGR1, EGR2, EGR3, CD28, BRCA2, CD3E, CD36, KIT, CCNE1, CAV1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, PSRC1, CREB5, EGF, CD4, RAN, EHF, MYB, NUP85, NFE2, FZD5, PAWR, PAX5, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, CDH3, CDH1, MAP2K2, F2R, ADAM2, MAFF, RFC1, CEBPE, KLF5, CHEK1, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, BCL11B, IFNA2, PRL, RHOG, TLR4, TLR2, LILRB1, CAMK4, ARID4A, HGS, ADRB2, STAP1, NLRP3, TGFB1, NR4A2, NR4A1, SLC40A1, CKAP2, DNM2, IFNG, DLL1, MEIS2, RBMX]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, CCL5, AKT1, CCL2, LYN, TGFB1, CD6, TLR4, TLR2]
GO:2000566;positive regulation of CD8-positive, alpha-beta T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1381.573672438919;9.083926447120524;0.0462400274809496;0.8969813732811862;[XCL1]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[CD1E, CD1B, CD1A, XCL1]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, AGTR1, CD36, PF4]
GO:0033603;positive regulation of dopamine secretion;9.0;1.0;0.896240625180289;9.628524252492122;382.96729536294987;7.9853141584524145;0.01281757072760856;0.8046099625986299;[CXCL12]
GO:2000562;negative regulation of CD4-positive, alpha-beta T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1433.7336516231012;8.390779266560578;0.04798577504331058;0.8615337942327104;[XCL1]
GO:2000563;positive regulation of CD4-positive, alpha-beta T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1383.791516303458;8.390779266560578;0.04631425671916583;0.8615337942327104;[XCL1]
GO:0035584;calcium-mediated signaling using intracellular calcium source;8.0;1.0;0.875;9.628524252492122;30.117246255164275;6.781341354126479;0.0010079971283984438;0.7217981122146513;[GRM5, CCL20, AZU1]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[IFNG, LRRK2]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, PTGS2, CXCL10, CD4, ALPL]
GO:0022029;telencephalon cell migration;6.0;0.6873818243518346;0.6668112247660618;8.68406264365127;21.32120993996455;6.250713103064308;7.136017088474478E-4;0.6427820713687392;[CX3CR1, NRP1, LRRK2, CXCL12, TNR]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[PF4]
GO:1904798;positive regulation of core promoter binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.59990527316089;7.9853141584524145;0.002095162493235609;0.7592887026755414;[IFNG]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, AKT1, MEF2C, IQGAP3, LYN, PLK2, CDK14, DUSP6, CIT, HBEGF, IL12RB2, GTF2H1, PKN1, IL5RA, FGF5, GRAP2, STK32B, KCNH1, MAP2K2, VRK1, NRBP1, MELK, BLK, PKMYT1, BMX, LAT, LRRK2, CCL8, CCL5, CCL2, TIE1, IL2RB, CCNH, CHEK1, TNFSF11, BTC, BTK, SIK1, EPHA3, PTK2, CTSG, CCR5, SPTAN1, MAP4K1, KIT, TLR7, SGK1, TLR4, TLR2, CAMK4, PDGFRB, CCNE1, CSF2RB, RASGRP4, TGFB1, GHR, TGFBR3, NCAM1, BUB1, EGF, WEE1, TEK]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, CXCL12, IFNA5, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, MMP12, IFNG, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, LILRB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, MEF2C, ATF3, ELANE, PKIG, EZH2, PAWR, PAX5, AES, MMP12, NR1H2, DACH1, TLE4, FOXO1, NACC2, WFS1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CD36, CCNE1, TGFB1, CBX4, CAV1, NR4A2, MXD1, IFNG, FBP1, MEIS2]
GO:0032747;positive regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.16763571524637;0.0021737836760178982;0.7408135829017477;[IFNG]
GO:0010835;regulation of protein ADP-ribosylation;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;75.95246883248204;7.57984905034425;0.0025420607790390634;0.7626338329336335;[IFNG]
GO:0070664;negative regulation of leukocyte proliferation;6.0;0.7140352122741334;0.6801379187272112;8.781226392104918;64.27901505963113;5.459585514144159;0.002151360786688069;0.6023237696801675;[TNFRSF13B, HAVCR2, ARG1, PAWR, PDCD1LG2, BTK, XCL1, CD274, CCL8, GPNMB, LYN, TGFB1, LILRB1, LILRB2, PKN1, FCGR2B]
GO:0050930;induction of positive chemotaxis;8.0;1.0;0.875;9.628524252492122;129.39753142075796;7.138016298065211;0.004330818926435078;0.7400384854347593;[CXCL12, AZU1]
GO:0071636;positive regulation of transforming growth factor beta production;6.0;0.7980440201809971;0.722142322680643;9.34084218004034;65.64212018022187;6.943860283624253;0.0021969826883592772;0.6782296504172152;[MYB, XCL1, PTGS2]
GO:0043615;astrocyte cell migration;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;22.237500671838706;7.9853141584524145;7.442691350351552E-4;0.7314896500084853;[CCL2, APCDD1]
GO:0045918;negative regulation of cytolysis;5.0;0.8259837884571596;0.7032329060895001;9.377209824211215;41.247147119458;8.390779266560578;0.0013805048940658876;0.7193458537639684;[PF4]
GO:1903237;negative regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;459.0491676986248;8.390779266560578;0.015363962525443897;0.8443458537639685;[CXCL12]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, AGTR1, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, CCR10, CCR1, CAV1, CXCL10, CXCL11, CD24, GPR18, CXCL9, FASLG, CCR9, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC1, AVPR1A, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, GPR6, P2RX5, CD4, F2RL3]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[, HP, CXCL13, PYCARD, IGHG1, IL6R, SLC11A1, RNASE6, RNASE3, CHIT1, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, IGHA1, ELANE, DEFA4, CAV1, PRG2, AZU1, DEFA1, PPBP, LYZ, IGKV3-20, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, ANXA3, TLR1, IGHD, BPI, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, PTAFR, NLRC4, IGKC, CCL2, CCL20, CD4, FCGR2B]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD36, CCL19, IFNG, TLR4, TLR2]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, ANXA1, CCL20, TNFRSF11A, LGALS3, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, PYCARD, CD28, XCL1, TLR4, TLR2]
